The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection
Open Access
- 15 May 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (10), 1489-1492
- https://doi.org/10.1086/587654
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004Antimicrobial Agents and Chemotherapy, 2007
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospitalJournal of Antimicrobial Chemotherapy, 2005
- Reassessment of Clostridium difficile Susceptibility to Metronidazole and VancomycinAntimicrobial Agents and Chemotherapy, 2002
- Metronidazole Resistance in Clostridium difficileClinical Infectious Diseases, 2000
- Comparison of Vancomycin, Teicoplanin, Metronidazole, and Fusidic Acid for the Treatment of Clostridium difficile--Associated DiarrheaClinical Infectious Diseases, 1996
- Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.Gut, 1986
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978
- Iatrogenic Staphylococcal EnterocolitisAnnals of Surgery, 1964
- Iron storage and transport in experimental hæmolytic anæmie in the albino ratThe Journal of Pathology and Bacteriology, 1962